Vapourtec’s R-Series flow chemistry system, equipped with a UV-150 photochemical reactor, has been cited in research by scientists* at Novo Nordisk in the C-terminal a-amination of peptides and ...

Cardiac problems associated with vascular endothelial growth factor inhibitors occur frequently in patients with cancer.

The trial is assessing the therapy for individuals with ischemic heart failure of minimised ejection fraction.

Bristol Myers Squibb today announced the Phase 3 ODYSSEY-HCM trial evaluating Camzyos (mavacamten) for the treatment of adult patients with symptomatic New York Heart Association (NYHA) class II-III ...

Fire1 announced positive results from the first-in-human study of its novel, implantable heart failure (HF) management system ...

DMD was first described by French neurologist Guillaume Benjamin Amand Duchenne in the 1860s. However, until the 1980s, ...

After an earlier trial showed patients with elevated levels of a cardiac stress marker benefited from its cell therapy, the firm shifted focus to this subset.

Here, we discover lysophospholipids as endogenous pannexin activators, using activity-guided fractionation of mouse tissue extracts combined with untargeted metabolomics and electrophysiology. We show ...

Several transcription factors in developing neurons exhibit broad-to-restricted expression patterns, but the relevance of ...

China again vowed to “fight to the end” against Donald Trump’s tariffs in a lengthy policy statement published Wednesday, ...